Vidyya Medical News Service
*
Volume 5 Issue 148 Published - 14:00 UTC 08:00 EST 28-May-2003 Next Update - 14:00 UTC 08:00 EST 29-May-2003
little clear gif used for spacer
.
*

FDA BSE update - Pet food from Canadian manufacturer tests positive for "mad cow disease"
The Food and Drug Administration (FDA) has learned from the government of Canada that rendered material from a Canadian cow that last week tested positive for bovine spongiform encephalopathy (BSE, also known as “mad cow disease”) may have been used to manufacture pet food, specifically dry dog food, some of which was reported to have been shipped to the United States. The Canadian government prevented the BSE positive cow from being processed for human food. Therefore, consumers can be assured that their food does not contain any remnants of the BSE positive cow.  more

*
No. I do not want to interpret mammograms in my future practice
A newly published survey of radiology residents revealed that although medical schools are providing more extensive training in breast imaging, the majority of residents do not want to interpret mammograms in their future practices. Researchers reported their findings in a study appearing in the June issue of the journal Radiology. more

 


*
Abciximab works on secondary clots in stroke patients
Many stroke patients can be treated with clot-busting drugs to reduce their chances of death and disability. But for some patients, the treatment is unsuccessful because the clots reappear soon after treatment. Now researchers have identified a drug that can break up those secondary clots, according to a study in the May 27 issue of Neurology, the scientific journal of the American Academy of Neurology.  more

*
Prescribing information: ReoPro (abciximab)
ReoPro (abciximab) is approved for use around the time of balloon angioplasty and related procedures (whether done electively or in the setting of acute coronary syndrome). Patients who took these drugs in clinical trials suffered fewer heart attacks and required fewer urgent procedures. The clinical trials included several thousand patients but did not provide evidence to evaluate the effect on long-term survival. The only important side effect from taking these new drugs that has been observed is excessive bleeding. is approved for use around the time of balloon angioplasty and related procedures (whether done electively or in the setting of acute coronary syndrome). Patients who took these drugs in clinical trials suffered fewer heart attacks and required fewer urgent procedures. The clinical trials included several thousand patients but did not provide evidence to evaluate the effect on long-term survival. The only important side effect from taking these new drugs that has been observed is excessive bleeding.  more

*
System takes from poor schools and gives to the rich, study shows
Because educational level is associated with level of health, Vidyya believes the following article, while out of the health subject matter somewhat, is an important one for our readers to ponder.  more

 
little clear gif used for a space